All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

UK researchers awarded £5.7m to explore epigenetic approaches for antiviral therapies

By

Charlotte Ridler

2h ago· 2 min readenNews

Summary

Researchers at Barts Cancer Institute, Queen Mary University of London, have been awarded £880,000 as part of a £5.7m national collaborative initiative called epiPRIME. The project explores how epigenetics — the processes controlling gene activation — can be harnessed to strengthen the immune system's ability to fight viruses. Led by Dr Chiara Herzog, the initiative focuses on epigenetically programming resilience through innate memory engineering.

Source

bskyUK researchers awarded £5.7m to explore epigenetic approaches for antiviral therapiesbci.qmul.ac.uk

Key quotes

· 3 pulled
Researchers at Barts Cancer Institute, Queen Mary University of London, have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics can be harnessed to strengthen our immune system's ability to fight viruses.
Dr Gabriella Ficz, Group Leader at Barts Cancer Institute, will receive £880,000 to support her team's contribution to the epiPRIME project.
The collaboration is led by Dr Chiara Herzog at the University...
Snippet from the RSS feed
Researchers at Barts Cancer Institute, Queen Mary University of London, have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics – the processes that control how genes are switched on and off – can be harnes

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.